Brief: Tela Bio Reports Fourth Quarter Results

TELA Bio

21/03/2023 20:04

March 21 (Reuters) - Tela Bio Inc  TELA.O :
    * TELA BIO REPORTS FOURTH QUARTER AND FULL YEAR 2022
FINANCIAL
RESULTS
    * Q4 REVENUE ROSE 39 PERCENT TO $11.6 MILLION
    * SEES FULL YEAR 2023 REVENUE IS PROJECTED TO RANGE FROM $60
MILLION TO $65 MILLION, REFLECTING GROWTH OF 45% TO 57% OVER
FULL YEAR 2022
    * SEES FULL YEAR 2023 REVENUE IS PROJECTED TO RANGE FROM $60
MILLION TO $65 MILLION, REFLECTING GROWTH OF 45% TO 57% OVER
FULL YEAR 2022
    * QTRLY  LOSS PER SHARE $0.52
    * Q4 EARNINGS PER SHARE VIEW $-0.55, REVENUE VIEW $13.2
MILLION --
REFINITIV IBES DATA
    * FY2023 REVENUE VIEW $59.6 MILLION -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX4b07h6 
Further company coverage:  TELA.O 

 ((Reuters.Briefs@thomsonreuters.com;))